Reported 2 days ago
Globe Life's stock rose nearly 3% after CFRA analyst Catherine Seifert upgraded her recommendation from hold to buy, increasing the price target from $130 to $155. This positive change followed the company's encouraging second-quarter results and the conclusion of an SEC investigation with no enforcement action against Globe Life, suggesting a strong outlook for the insurer.
Source: YAHOO